Pentrexcilina Severe Allergy
Product Images NDC 69729-106

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pentrexcilina Severe Allergy (NDC 69729-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opmx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pentrexcilina Display Panel (Pentrexcilina Dislpay Panel)

Pentrexcilina Display Panel (Pentrexcilina Dislpay Panel)
This is a description of two types of allergy relief medication: Daytime Xtreme Allergy Relief and Nighttime Severe Allergy Relief. The Daytime relief is non-drowsy and provides 24-hour allergy relief for symptoms such as sneezing, runny nose, itchy and watery eyes, and scratchy throat. The Nighttime relief contains a sleep aid, Diphenhydramine HCI 25mg, for relieving severe allergy symptoms during the night.*
FDA Label Image

Night Time (Principal Display Panel Night Time)

Night Time (Principal Display Panel Night Time)
This text appears to be the information provided for a medicine, likely a medicine in tablet form. It mentions the active ingredient as an antihistamine and lists the possible uses for temporary relief of symptoms such as sinus congestion, sneezing, runny nose, and symptoms of the common cold. The text also includes warnings about not using the product if allergic to any of the ingredients, seeking medical advice before use in certain conditions, and directions for usage based on age groups. Inactive ingredients are also listed, along with contact information for questions or comments.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.